Protein-binding microarray analysis of tumor suppressor AP2α target gene specificity.

Area of Science:

• Molecular Biology
• Genomics
• Cancer Research

Background:

• Transcription factors regulate crucial cellular processes and are implicated in diseases.
• AP2α is a tumor suppressor with a significant role in cellular regulation.
• Developing efficient methods to study DNA-binding specificity of transcription factors is essential.

Purpose of the Study:

• To evaluate protein-binding microarrays (PBM) for assessing the DNA-binding specificity of the tumor suppressor AP2α.
• To identify novel AP2α target genes in healthy and breast tumor tissues.
• To understand the role of AP2α in cancer chemoresistance.

Main Methods:

• Utilized protein-binding microarrays (PBM) to probe AP2α association with 6000 human genomic DNA regulatory sequences.
• Compared PBM binding affinities with quantitative surface plasmon resonance assays.
• Analyzed human healthy and breast tumor tissue extracts using PBM.

Main Results:

• PBM demonstrated accurate relative binding affinities compared to surface plasmon resonance.
• Identified previously unknown AP2α target genes in breast tumor tissues.
• Confirmed experimental binding and regulation of novel AP2α targets in human carcinoma cells, linking them to tumor progression and chemoresistance.

Conclusions:

• PBM is a quantitative and accurate assay for determining the specificity and activity of tumor suppressor proteins in clinical samples.
• The study provides a molecular basis for AP2α's role in cancer chemoresistance.
• This approach effectively integrates genomic and proteomic data for clinical sample analysis.